Ionis Pharmaceuticals, Inc.
$IONS
Public valuation for Ionis Pharmaceuticals, Inc. (IONS). Fair value, signal, and key metrics — no sign-in required.
Current Price
$51.77
74% Overvalued
Fair Value Estimate
$13
📉
Distressed
Negative earnings with declining revenue
Analyst Consensus
Target: $90.80
75% higher than current
Key Metrics
Market Cap
$8.6B
Forward P/E
90.9x
Operating Margin
-38.2%
Revenue Growth
-11.5%
Get free watchlist alerts
Join the waitlist for valuation updates on $IONS and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.